A graduate of Glasgow University (1979), Dr Dobson entered radiology after obtaining the MRCP (UK) in 1982.  In 1987, she was appointed as Consultant Radiologist to the Western Infirmary, Glasgow with the responsibility of setting up the first NHS funded screening facility in Scotland, working closely with Professor David George.

Initially responsible for the screening of the eligible population of half of Greater Glasgow, Dr Dobson developed the service over a period of 4 years to take on the administration of the screening of half of the Scottish population – this now requires the overseeing of the screening of approximately 80,000 women per annum – the largest screening centre in the UK.  The team lead by Dr Hilary Dobson is now responsible for leading provision of radiology support to 5 busy symptomatic breast units in the Greater Glasgow area and the combined screening and sympromatic service diagnoses, approximately 1,000 annually.

In addition to her clinical responsibilities, Dr Dobson is Medical Advisor for Quality Assurance for the Scottish Breast Screening Programme and a member of the National Advisory Group for screening in Scotland.  Her main areas of research relate to image guided biopsy and more recently digital imaging.  Dr Dobson was Clinical Lead of the WoSCAN Breast Network from December 2008 until August 2011.  In July she was appoiinted successor to Dr Bob Masterton as Regional Lead Cancer Clinician for WoSCAN, and, in this capacity, she is a member of the Detect Cancer Early Programme Board.  As of 1st May 2012, she took up the post of Chair, National Cancer Quality Steering Group.

  • The Scottish Cancer Foundation Prize & Evans Forest Medal 2021

    Theme: outstanding contribution to the maintenance and/or recovery of cancer services during the COVID-19 pandemic. Winner: Miss Theofano Tikka, MSc, FRCS (ORL-HNS) Recently completed ENT Registrar training (West of Scotland Deanery) PhD candidate (Strathclyde University) Current post-CCT fellow at the Royal Marsden Hospital, London The Scottish Cancer Foundation Prize and

  • The Scottish Cancer Foundation 2022 Lecture

    HOPES AND HYPES: THE ROLE OF GENETICS IN CANCER PREVENTION AND TREATMENT Professor Anneke Lucassen The Royal Society of Edinburgh in partnership with the Scottish Cancer Foundation recently held this event featuring Professor Anneke Lucassen, Professor of Genomic Medicine and Director of the Centre for Personalised Medicine, University of Oxford.

  • The 2019 winner of the Scottish Cancer Foundation Prize and Evans Forrest Medal is Dr. Christine Campbell from The University of Edinburgh.

    Dr Campbell stood out to the Board of Directors due to her contribution to cancer screening, leading a series of research studies which have improved the understanding and effectiveness of screening programmes both in the UK and overseas. In addition, Dr Campbell’s work has sought to understand the factors that

  • New PhD Opportunity: Doctoral Training Fellowship in Cancer Prevention

    DEADLINE EXTENDED TO 31ST MAY 2021 The Scottish Cancer Foundation (SCF) focuses on Cancer Prevention, and wishes to promote research, collaborative working across Scotland and public engagement in this area.  Accordingly, the Foundation wishes to invest in the future of Cancer Prevention by providing motivated early-career individuals with research training

  • The Scottish Cancer Foundation Prize & Evans Forrest Medal

    The Scottish Cancer Foundation invites nominations for the 2021 Prize which will be for an individual or organisation that has made an outstanding contribution to the maintenance and/or recovery of cancer services during the COVID-19 pandemic. Applicants may be nominated or self-nominated. The applicant(s) must be living and working in